| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ryanodine-sensitive calcium-release channel activity | 1.59e-06 | 4 | 148 | 3 | GO:0005219 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | VPS4A SMCHD1 ABCB5 WRN SRP54 ABCC6 EIF4A1 EIF4A2 AFG3L2 ABCB11 KIF14 CHD6 POLQ ABCG8 | 5.33e-06 | 441 | 148 | 14 | GO:0016887 |
| GeneOntologyMolecularFunction | calcium-induced calcium release activity | 7.85e-06 | 6 | 148 | 3 | GO:0048763 | |
| GeneOntologyMolecularFunction | calcium ion binding | CAPN14 SWAP70 FSTL5 PCLO FKBP9 PKD1L2 ITIH4 RYR1 RYR2 RYR3 CELSR1 THBS4 SLC25A12 UMODL1 C1R CDH10 CDH12 | 4.14e-05 | 749 | 148 | 17 | GO:0005509 |
| GeneOntologyMolecularFunction | ATP-dependent activity | DNHD1 VPS4A SMCHD1 ABCB5 WRN SRP54 ABCC6 EIF4A1 EIF4A2 AFG3L2 ABCB11 KIF14 CHD6 POLQ ABCG8 | 5.30e-05 | 614 | 148 | 15 | GO:0140657 |
| GeneOntologyMolecularFunction | tRNA-4-demethylwyosine synthase activity | 5.46e-05 | 2 | 148 | 2 | GO:0102521 | |
| GeneOntologyMolecularFunction | ribonucleoside triphosphate phosphatase activity | RAB12 VPS4A SMCHD1 RNF112 ABCB5 WRN SRP54 ABCC6 EIF4A1 EIF4A2 AFG3L2 RAB2B ABCB11 KIF14 CHD6 POLQ ABCG8 | 6.32e-05 | 775 | 148 | 17 | GO:0017111 |
| GeneOntologyMolecularFunction | xenobiotic transmembrane transporter activity | 1.13e-04 | 34 | 148 | 4 | GO:0042910 | |
| GeneOntologyMolecularFunction | C-rich single-stranded DNA binding | 1.63e-04 | 3 | 148 | 2 | GO:1990829 | |
| GeneOntologyMolecularFunction | pyrophosphatase activity | RAB12 VPS4A SMCHD1 RNF112 ABCB5 WRN SRP54 ABCC6 EIF4A1 EIF4A2 AFG3L2 RAB2B ABCB11 KIF14 CHD6 POLQ ABCG8 | 1.65e-04 | 839 | 148 | 17 | GO:0016462 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides | RAB12 VPS4A SMCHD1 RNF112 ABCB5 WRN SRP54 ABCC6 EIF4A1 EIF4A2 AFG3L2 RAB2B ABCB11 KIF14 CHD6 POLQ ABCG8 | 1.67e-04 | 840 | 148 | 17 | GO:0016817 |
| GeneOntologyMolecularFunction | hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides | RAB12 VPS4A SMCHD1 RNF112 ABCB5 WRN SRP54 ABCC6 EIF4A1 EIF4A2 AFG3L2 RAB2B ABCB11 KIF14 CHD6 POLQ ABCG8 | 1.67e-04 | 840 | 148 | 17 | GO:0016818 |
| GeneOntologyMolecularFunction | ABC-type xenobiotic transporter activity | 1.70e-04 | 15 | 148 | 3 | GO:0008559 | |
| GeneOntologyMolecularFunction | intracellularly gated calcium channel activity | 3.00e-04 | 18 | 148 | 3 | GO:0015278 | |
| GeneOntologyMolecularFunction | ABC-type transporter activity | 4.74e-04 | 49 | 148 | 4 | GO:0140359 | |
| GeneOntologyMolecularFunction | oxo-acid-lyase activity | 1.12e-03 | 7 | 148 | 2 | GO:0016833 | |
| GeneOntologyMolecularFunction | ligand-gated calcium channel activity | 1.54e-03 | 31 | 148 | 3 | GO:0099604 | |
| GeneOntologyMolecularFunction | calmodulin binding | 1.66e-03 | 230 | 148 | 7 | GO:0005516 | |
| GeneOntologyBiologicalProcess | cellular response to alkaloid | 8.94e-06 | 40 | 146 | 5 | GO:0071312 | |
| GeneOntologyCellularComponent | platelet dense granule lumen | 1.15e-04 | 14 | 146 | 3 | GO:0031089 | |
| Domain | Ryanodine_rcpt | 4.78e-07 | 3 | 147 | 3 | IPR003032 | |
| Domain | Ryanrecept_TM4-6 | 4.78e-07 | 3 | 147 | 3 | IPR009460 | |
| Domain | RyR | 4.78e-07 | 3 | 147 | 3 | PF02026 | |
| Domain | RR_TM4-6 | 4.78e-07 | 3 | 147 | 3 | PF06459 | |
| Domain | Ryan_recept | 4.78e-07 | 3 | 147 | 3 | IPR013333 | |
| Domain | RIH_assoc-dom | 9.39e-06 | 6 | 147 | 3 | IPR013662 | |
| Domain | Ins145_P3_rec | 9.39e-06 | 6 | 147 | 3 | PF08709 | |
| Domain | RIH_assoc | 9.39e-06 | 6 | 147 | 3 | PF08454 | |
| Domain | RIH_dom | 9.39e-06 | 6 | 147 | 3 | IPR000699 | |
| Domain | Ins145_P3_rcpt | 9.39e-06 | 6 | 147 | 3 | IPR014821 | |
| Domain | Ryanodine_recept-rel | 9.39e-06 | 6 | 147 | 3 | IPR015925 | |
| Domain | - | 9.39e-06 | 6 | 147 | 3 | 1.25.10.30 | |
| Domain | RYDR_ITPR | 9.39e-06 | 6 | 147 | 3 | PF01365 | |
| Domain | MIR | 5.50e-05 | 10 | 147 | 3 | PF02815 | |
| Domain | MIR_motif | 5.50e-05 | 10 | 147 | 3 | IPR016093 | |
| Domain | MIR | 5.50e-05 | 10 | 147 | 3 | PS50919 | |
| Domain | MIR | 5.50e-05 | 10 | 147 | 3 | SM00472 | |
| Domain | EIF4A1/2 | 6.15e-05 | 2 | 147 | 2 | IPR031258 | |
| Domain | tRNA_wybutosine-synth | 6.15e-05 | 2 | 147 | 2 | IPR013917 | |
| Domain | Wyosine_form | 6.15e-05 | 2 | 147 | 2 | PF08608 | |
| Domain | - | RAB12 DNHD1 VPS4A RNF112 ABCB5 WRN SRP54 ABCC6 SBNO1 EIF4A1 EIF4A2 AFG3L2 RAB2B ABCB11 CHD6 POLQ ABCG8 | 8.19e-05 | 746 | 147 | 17 | 3.40.50.300 |
| Domain | P-loop_NTPase | RAB12 DNHD1 VPS4A RNF112 ABCB5 WRN SRP54 ABCC6 SBNO1 EIF4A1 EIF4A2 AFG3L2 RAB2B ABCB11 KIF14 CHD6 POLQ ABCG8 | 1.23e-04 | 848 | 147 | 18 | IPR027417 |
| Domain | CH | 1.59e-04 | 65 | 147 | 5 | SM00033 | |
| Domain | - | 1.84e-04 | 3 | 147 | 2 | 1.10.10.430 | |
| Domain | PP2C_C | 1.84e-04 | 3 | 147 | 2 | PF07830 | |
| Domain | PP2C_C | 1.84e-04 | 3 | 147 | 2 | IPR012911 | |
| Domain | CH | 2.26e-04 | 70 | 147 | 5 | PF00307 | |
| Domain | - | 2.42e-04 | 71 | 147 | 5 | 1.10.418.10 | |
| Domain | CH | 2.76e-04 | 73 | 147 | 5 | PS50021 | |
| Domain | CH-domain | 3.13e-04 | 75 | 147 | 5 | IPR001715 | |
| Domain | ABC_transporter_CS | 3.27e-04 | 42 | 147 | 4 | IPR017871 | |
| Domain | EF-hand-dom_pair | 4.57e-04 | 287 | 147 | 9 | IPR011992 | |
| Domain | EF_hand_dom | 5.09e-04 | 232 | 147 | 8 | IPR002048 | |
| Domain | ABC_tran | 5.48e-04 | 48 | 147 | 4 | PF00005 | |
| Domain | ABC_TRANSPORTER_2 | 5.48e-04 | 48 | 147 | 4 | PS50893 | |
| Domain | ABC_TRANSPORTER_1 | 5.93e-04 | 49 | 147 | 4 | PS00211 | |
| Domain | ABC_transporter-like | 6.40e-04 | 50 | 147 | 4 | IPR003439 | |
| Domain | ABC_membrane | 8.56e-04 | 24 | 147 | 3 | PF00664 | |
| Domain | ITI_HC_C | 9.04e-04 | 6 | 147 | 2 | IPR010600 | |
| Domain | ITI_HC_C | 9.04e-04 | 6 | 147 | 2 | PF06668 | |
| Domain | AAA | 9.82e-04 | 144 | 147 | 6 | SM00382 | |
| Domain | AAA+_ATPase | 9.82e-04 | 144 | 147 | 6 | IPR003593 | |
| Domain | - | 1.10e-03 | 261 | 147 | 8 | 1.10.238.10 | |
| Domain | PTPc_motif | 1.20e-03 | 59 | 147 | 4 | SM00404 | |
| Domain | Tyr_Pase_cat | 1.20e-03 | 59 | 147 | 4 | IPR003595 | |
| Domain | ABC_TM1F | 1.35e-03 | 28 | 147 | 3 | PS50929 | |
| Domain | ABC1_TM_dom | 1.35e-03 | 28 | 147 | 3 | IPR011527 | |
| Domain | Helicase_C | 1.58e-03 | 107 | 147 | 5 | PF00271 | |
| Domain | HELICc | 1.58e-03 | 107 | 147 | 5 | SM00490 | |
| Domain | PH | 1.63e-03 | 278 | 147 | 8 | SM00233 | |
| Domain | Helicase_C | 1.64e-03 | 108 | 147 | 5 | IPR001650 | |
| Domain | Flavodoxin/NO_synth | 1.67e-03 | 8 | 147 | 2 | IPR008254 | |
| Domain | Cullin_neddylation_domain | 1.67e-03 | 8 | 147 | 2 | IPR019559 | |
| Domain | Flavdoxin-like | 1.67e-03 | 8 | 147 | 2 | IPR001094 | |
| Domain | Cullin_Nedd8 | 1.67e-03 | 8 | 147 | 2 | PF10557 | |
| Domain | VIT | 1.67e-03 | 8 | 147 | 2 | PF08487 | |
| Domain | FLAVODOXIN_LIKE | 1.67e-03 | 8 | 147 | 2 | PS50902 | |
| Domain | Cullin_Nedd8 | 1.67e-03 | 8 | 147 | 2 | SM00884 | |
| Domain | VIT | 1.67e-03 | 8 | 147 | 2 | SM00609 | |
| Domain | Flavodoxin_1 | 1.67e-03 | 8 | 147 | 2 | PF00258 | |
| Domain | PH_DOMAIN | 1.67e-03 | 279 | 147 | 8 | PS50003 | |
| Domain | PH_domain | 1.71e-03 | 280 | 147 | 8 | IPR001849 | |
| Domain | HELICASE_CTER | 1.71e-03 | 109 | 147 | 5 | PS51194 | |
| Domain | HELICASE_ATP_BIND_1 | 1.71e-03 | 109 | 147 | 5 | PS51192 | |
| Domain | DEXDc | 1.71e-03 | 109 | 147 | 5 | SM00487 | |
| Domain | Helicase_ATP-bd | 1.78e-03 | 110 | 147 | 5 | IPR014001 | |
| Domain | PH_dom-like | ARHGAP42 SWAP70 ARHGAP10 MTMR8 PSD3 SPTBN5 JAK2 IQSEC1 ROCK1 ARHGEF6 | 2.03e-03 | 426 | 147 | 10 | IPR011993 |
| Domain | rSAM | 2.14e-03 | 9 | 147 | 2 | IPR007197 | |
| Domain | PH_dom-spectrin-type | 2.14e-03 | 9 | 147 | 2 | IPR001605 | |
| Domain | Cullin_homology | 2.14e-03 | 9 | 147 | 2 | IPR016158 | |
| Domain | Radical_SAM | 2.14e-03 | 9 | 147 | 2 | PF04055 | |
| Domain | PH | 2.27e-03 | 229 | 147 | 7 | PF00169 | |
| Domain | Tyr_Pase_AS | 2.63e-03 | 73 | 147 | 4 | IPR016130 | |
| Domain | DEAD/DEAH_box_helicase_dom | 2.63e-03 | 73 | 147 | 4 | IPR011545 | |
| Domain | DEAD | 2.63e-03 | 73 | 147 | 4 | PF00270 | |
| Domain | Cullin | 2.66e-03 | 10 | 147 | 2 | PF00888 | |
| Domain | VIT | 2.66e-03 | 10 | 147 | 2 | PS51468 | |
| Domain | VIT | 2.66e-03 | 10 | 147 | 2 | IPR013694 | |
| Domain | - | 2.66e-03 | 10 | 147 | 2 | 3.40.50.360 | |
| Domain | Flavoprotein-like_dom | 2.66e-03 | 10 | 147 | 2 | IPR029039 | |
| Domain | CULLIN_2 | 2.66e-03 | 10 | 147 | 2 | PS50069 | |
| Domain | Cullin_N | 2.66e-03 | 10 | 147 | 2 | IPR001373 | |
| Domain | CULLIN_1 | 2.66e-03 | 10 | 147 | 2 | PS01256 | |
| Domain | SM22_calponin | 3.23e-03 | 11 | 147 | 2 | IPR003096 | |
| Domain | - | ARHGAP42 SWAP70 ARHGAP10 MTMR8 PSD3 SPTBN5 IQSEC1 ROCK1 ARHGEF6 | 3.85e-03 | 391 | 147 | 9 | 2.30.29.30 |
| Domain | WWE | 3.86e-03 | 12 | 147 | 2 | PF02825 | |
| Domain | WWE-dom | 3.86e-03 | 12 | 147 | 2 | IPR004170 | |
| Domain | WWE | 3.86e-03 | 12 | 147 | 2 | PS50918 | |
| Domain | PP2C_BS | 3.86e-03 | 12 | 147 | 2 | IPR000222 | |
| Domain | PTPase_domain | 4.09e-03 | 41 | 147 | 3 | IPR000242 | |
| Domain | Y_phosphatase | 4.09e-03 | 41 | 147 | 3 | PF00102 | |
| Domain | - | 4.38e-03 | 42 | 147 | 3 | 3.20.20.70 | |
| Domain | I-BAR_dom | 4.53e-03 | 13 | 147 | 2 | IPR013606 | |
| Domain | TYR_PHOSPHATASE_1 | 4.75e-03 | 86 | 147 | 4 | PS00383 | |
| Domain | Aldolase_TIM | 5.00e-03 | 44 | 147 | 3 | IPR013785 | |
| Domain | Rho_GTPase_activation_prot | 5.15e-03 | 88 | 147 | 4 | IPR008936 | |
| Domain | PP2C_SIG | 5.26e-03 | 14 | 147 | 2 | SM00331 | |
| Domain | ER_TARGET | 6.01e-03 | 47 | 147 | 3 | PS00014 | |
| Domain | - | 6.01e-03 | 47 | 147 | 3 | 3.30.420.10 | |
| Domain | FH2 | 6.04e-03 | 15 | 147 | 2 | PS51444 | |
| Pubmed | MIA3 PDPR ARHGAP10 SUN1 MTMR8 PSD3 PTPN23 HUWE1 CUL7 CCDC61 CDC14A PPM1A PPM1B PTPN2 AKAP9 LNPEP CRLF3 AFG3L2 MKI67 FMN2 KIF14 LRP6 CDK5RAP2 ROCK1 UQCRC2 PC UTRN PRRC2B | 1.27e-14 | 1049 | 151 | 28 | 27880917 | |
| Pubmed | SUMF2 MIA3 SWAP70 SMCHD1 USP24 FKBP9 SRP54 PTPN23 URB2 RPL23 NAA35 LNPEP MORF4L1 EIF4A1 EIF4A2 AFG3L2 MKI67 UGGT2 FAM3C TAGLN2 UQCRC2 POGLUT2 RIOK2 PCBP2 ALDH7A1 PRRC2B | 7.40e-11 | 1297 | 151 | 26 | 33545068 | |
| Pubmed | HNRNPDL MIA3 RAPGEF6 IQGAP2 SUN1 SRP54 PTPN23 HUWE1 THOC2 SLC1A3 TYW1B EIF4A2 ZBTB10 FMN2 CDK5RAP2 ROCK1 TYW1 POGLUT2 CPLANE1 UTRN ARHGEF6 PARP12 | 2.00e-09 | 1084 | 151 | 22 | 11544199 | |
| Pubmed | Chromatin Remodeling BAF155 Subunit Regulates the Genesis of Basal Progenitors in Developing Cortex. | 1.49e-08 | 38 | 151 | 6 | 30240734 | |
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | HNRNPDL SMCHD1 WRN USP24 HUWE1 THOC2 ITIH4 SNRPGP15 RPL23 ORC2 SLC25A12 EIF4A1 EIF4A2 AFG3L2 MKI67 IQSEC1 CHD6 TAGLN2 UQCRC2 PC RIOK2 PCBP2 | 6.55e-08 | 1318 | 151 | 22 | 30463901 |
| Pubmed | 8.02e-08 | 3 | 151 | 3 | 18403125 | ||
| Pubmed | 8.02e-08 | 3 | 151 | 3 | 7876312 | ||
| Pubmed | 8.02e-08 | 3 | 151 | 3 | 22948152 | ||
| Pubmed | Developmental changes in expression of the three ryanodine receptor mRNAs in the mouse brain. | 8.02e-08 | 3 | 151 | 3 | 10788707 | |
| Pubmed | Ca(2+)-induced Ca2+ release in myocytes from dyspedic mice lacking the type-1 ryanodine receptor. | 8.02e-08 | 3 | 151 | 3 | 7621815 | |
| Pubmed | Molecular identification of the ryanodine receptor pore-forming segment. | 8.02e-08 | 3 | 151 | 3 | 10473538 | |
| Pubmed | 8.02e-08 | 3 | 151 | 3 | 18434746 | ||
| Pubmed | SPRY domains in ryanodine receptors (Ca(2+)-release channels). | 8.02e-08 | 3 | 151 | 3 | 9204703 | |
| Pubmed | 8.02e-08 | 3 | 151 | 3 | 21881589 | ||
| Pubmed | Isoform-dependent formation of heteromeric Ca2+ release channels (ryanodine receptors). | 8.02e-08 | 3 | 151 | 3 | 12213830 | |
| Pubmed | 8.02e-08 | 3 | 151 | 3 | 9242641 | ||
| Pubmed | 8.02e-08 | 3 | 151 | 3 | 25239916 | ||
| Pubmed | 8.02e-08 | 3 | 151 | 3 | 18643873 | ||
| Pubmed | 8.02e-08 | 3 | 151 | 3 | 11159936 | ||
| Pubmed | 8.02e-08 | 3 | 151 | 3 | 7959768 | ||
| Pubmed | The organization of proteins in the human red blood cell membrane. A review. | 8.02e-08 | 3 | 151 | 3 | 4600883 | |
| Pubmed | 8.02e-08 | 3 | 151 | 3 | 7635066 | ||
| Pubmed | Irisin Mediates Effects on Bone and Fat via αV Integrin Receptors. | RAB12 PCBP3 PDPR FKBP9 PTPN23 SBSN RPL23 SLC25A12 AKAP9 DPP9 NDUFAF1 CLCN6 LNPEP EIF4A1 EIF4A2 UGDH IQSEC1 C1R UGGT2 FAM3C UQCRC2 POGLUT2 PARP12 | 8.07e-08 | 1451 | 151 | 23 | 30550785 |
| Pubmed | HNRNPDL VPS4A SMCHD1 SUN1 HUWE1 HEPH PPM1B RPL23 SLC25A12 LNPEP EIF4A1 AFG3L2 UGGT2 UQCRC2 PCBP2 | 8.26e-08 | 613 | 151 | 15 | 22268729 | |
| Pubmed | 3.20e-07 | 4 | 151 | 3 | 33581058 | ||
| Pubmed | Ryanodine receptor calcium release channels: lessons from structure-function studies. | 3.20e-07 | 4 | 151 | 3 | 23413940 | |
| Pubmed | 3.20e-07 | 4 | 151 | 3 | 9607712 | ||
| Pubmed | 3.20e-07 | 4 | 151 | 3 | 23482488 | ||
| Pubmed | 3.20e-07 | 4 | 151 | 3 | 18206662 | ||
| Pubmed | 3.20e-07 | 4 | 151 | 3 | 9384575 | ||
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | HNRNPDL VPS4A SMCHD1 SRP54 PTPN23 URB2 HUWE1 RPL23 NAA35 SLC25A12 EIF4A1 AFG3L2 UGDH MKI67 IQSEC1 ZBTB10 UQCRC2 RIOK2 UTRN ALDH7A1 PARP12 | 4.43e-07 | 1353 | 151 | 21 | 29467282 |
| Pubmed | 7.97e-07 | 5 | 151 | 3 | 23918386 | ||
| Pubmed | Protein kinase C-epsilon regulates local calcium signaling in airway smooth muscle cells. | 7.97e-07 | 5 | 151 | 3 | 19011160 | |
| Pubmed | DMXL2 DAZAP2 CAMK1 HUWE1 RYR3 FOCAD ZNF334 SBNO1 SCG2 MORF4L1 EIF4A1 EIF4A2 FMN2 DAAM2 CHD6 IFT122 PC ST18 UTRN ALDH5A1 | 8.19e-07 | 1285 | 151 | 20 | 35914814 | |
| Pubmed | SMCHD1 ZNF629 SRP54 HUWE1 THOC2 CCDC61 ZNF608 AFG3L2 KIF14 ROCK1 CHD6 TAGLN2 UTRN ARHGEF6 | 9.50e-07 | 645 | 151 | 14 | 25281560 | |
| Pubmed | DMXL2 MIA3 RAPGEF6 ZNF629 CUL5 EIF4A1 AFG3L2 UGDH UGGT2 IFT122 UQCRC2 RIOK2 PRRC2B PARP12 | 1.04e-06 | 650 | 151 | 14 | 38777146 | |
| Pubmed | 1.08e-06 | 42 | 151 | 5 | 7584044 | ||
| Pubmed | DMXL2 MIA3 IQGAP2 HUWE1 SLC1A3 FAM81A ITIH4 AKAP9 KIAA1217 MORF4L1 EIF4A1 EIF4A2 IQSEC1 CDK5RAP2 ROCK1 CDH10 PRRC2B | 1.09e-06 | 963 | 151 | 17 | 28671696 | |
| Pubmed | 1.59e-06 | 6 | 151 | 3 | 19549818 | ||
| Pubmed | Rectification of muscle and nerve deficits in paralyzed ryanodine receptor type 1 mutant embryos. | 1.59e-06 | 6 | 151 | 3 | 26025922 | |
| Pubmed | 1.59e-06 | 6 | 151 | 3 | 23463619 | ||
| Pubmed | FKBP12.6 and cADPR regulation of Ca2+ release in smooth muscle cells. | 1.59e-06 | 6 | 151 | 3 | 14592808 | |
| Pubmed | Essential Roles of Intracellular Calcium Release Channels in Muscle, Brain, Metabolism, and Aging. | 1.59e-06 | 6 | 151 | 3 | 25966694 | |
| Pubmed | 1.59e-06 | 6 | 151 | 3 | 19009018 | ||
| Pubmed | 1.59e-06 | 6 | 151 | 3 | 20519450 | ||
| Pubmed | IP3Rs are sufficient for dendritic cell Ca2+ signaling in the absence of RyR1. | 1.59e-06 | 6 | 151 | 3 | 16844763 | |
| Pubmed | IQGAP2 SMCHD1 WRN SRP54 THOC2 ITIH3 SBSN SNRPGP15 AKAP9 UGDH MKI67 IQSEC1 RAB2B TAGLN2 UQCRC2 PC RIOK2 PCBP2 PRRC2B PARP12 | 2.20e-06 | 1371 | 151 | 20 | 36244648 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | HNRNPDL SMCHD1 SUN1 URB2 HUWE1 CUL7 THOC2 SNRPGP15 RPL23 EIF4A1 AFG3L2 MKI67 KIF14 TAGLN2 UQCRC2 PCBP2 UTRN | 2.48e-06 | 1024 | 151 | 17 | 24711643 |
| Pubmed | KAP1 facilitates reinstatement of heterochromatin after DNA replication. | HNRNPDL PDPR IQGAP2 SRP54 PTPN23 URB2 HUWE1 RPL23 PTPN2 SLC25A12 EIF4A1 EIF4A2 UQCRC2 PC | 2.63e-06 | 704 | 151 | 14 | 29955894 |
| Pubmed | 2.77e-06 | 7 | 151 | 3 | 11860456 | ||
| Pubmed | 2.77e-06 | 7 | 151 | 3 | 20962236 | ||
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | RAPGEF6 SMCHD1 SRP54 PTPN23 THOC2 RPL23 ORC2 KIAA1217 AFG3L2 MKI67 TAGLN2 PC PCBP2 UTRN PRRC2B PARP12 | 3.37e-06 | 934 | 151 | 16 | 33916271 |
| Pubmed | Voltage-dependent conformational changes of Kv1.3 channels activate cell proliferation. | 3.82e-06 | 208 | 151 | 8 | 33230847 | |
| Pubmed | DMXL2 IQGAP2 PCLO FKBP9 PSD3 SLC1A3 CUL5 RPL23 THBS4 SLC25A12 CLCN6 KIAA1217 SCN2A AFG3L2 IQSEC1 UQCRC2 PC UTRN ALDH7A1 PRRC2B | 4.18e-06 | 1431 | 151 | 20 | 37142655 | |
| Pubmed | 4.42e-06 | 8 | 151 | 3 | 11784029 | ||
| Pubmed | Roles of IP3R and RyR Ca2+ channels in endoplasmic reticulum stress and beta-cell death. | 4.42e-06 | 8 | 151 | 3 | 19033399 | |
| Pubmed | RAPGEF6 SWAP70 SMCHD1 USP24 PTPN23 HUWE1 THOC2 KIF14 TAGLN2 PC PCBP2 PRRC2B | 5.46e-06 | 549 | 151 | 12 | 38280479 | |
| Pubmed | HNRNPDL GINS3 SRP54 HUWE1 SBSN CUL5 SNRPGP15 RPL23 ORC2 SLC25A12 MORF4L1 EIF4A1 AFG3L2 ZBTB10 UQCRC2 PC RIOK2 PCBP2 ALDH7A1 | 5.74e-06 | 1335 | 151 | 19 | 29229926 | |
| Pubmed | Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms. | SUMF2 SRP54 URB2 SLC1A3 B3GAT3 PPM1A AKAP9 SBNO1 CEP250 CDK5RAP2 UGGT2 POGLUT2 ALDH7A1 PRRC2B | 5.76e-06 | 754 | 151 | 14 | 33060197 |
| Pubmed | GINS3 ARHGAP10 VPS4A ZNF629 CUL7 ITIH4 ARHGAP4 NAA35 SLC25A12 ZNF608 KMT5B MORF4L1 AFG3L2 IQSEC1 ZBTB10 FMN2 PRRC2B | 7.72e-06 | 1116 | 151 | 17 | 31753913 | |
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | HNRNPDL MIA3 PDPR PCLO SUN1 SRP54 HUWE1 CUL7 SPTBN5 RPL23 PTPN2 SLC25A12 AKAP9 NDUFAF1 KIAA1217 AFG3L2 CDK5RAP2 UQCRC2 ALDH5A1 PRRC2B | 8.05e-06 | 1496 | 151 | 20 | 32877691 |
| Pubmed | Functional consequences of necdin nucleocytoplasmic localization. | 8.95e-06 | 64 | 151 | 5 | 22442722 | |
| Pubmed | LncRNAs-directed PTEN enzymatic switch governs epithelial-mesenchymal transition. | 9.32e-06 | 168 | 151 | 7 | 30631154 | |
| Pubmed | DMXL2 MIA3 PCLO SUN1 USP24 PSD3 HUWE1 SLC1A3 RYR2 RPL23 PTPN2 KIAA1217 AFG3L2 IQSEC1 UQCRC2 PC ALDH5A1 | 1.01e-05 | 1139 | 151 | 17 | 36417873 | |
| Pubmed | SUMF2 SASH1 DAZAP2 HUWE1 RYR2 CUL5 LNPEP CEP250 ROCK1 CHD6 PCBP2 UTRN | 1.14e-05 | 591 | 151 | 12 | 15231748 | |
| Pubmed | 1.23e-05 | 244 | 151 | 8 | 30349055 | ||
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | MIA3 PCLO HUWE1 RYR1 RPL23 NAA35 AKAP9 EIF4A1 DAAM2 ZNF561 TAGLN2 PC PCBP2 UTRN | 1.24e-05 | 807 | 151 | 14 | 30575818 |
| Pubmed | Regulation of epidermal differentiation through KDF1-mediated deubiquitination of IKKα. | 1.57e-05 | 182 | 151 | 7 | 32239614 | |
| Pubmed | 1.72e-05 | 12 | 151 | 3 | 19095005 | ||
| Pubmed | 1.72e-05 | 12 | 151 | 3 | 21119685 | ||
| Pubmed | 1.87e-05 | 2 | 151 | 2 | 9489997 | ||
| Pubmed | 1.87e-05 | 2 | 151 | 2 | 17259277 | ||
| Pubmed | 1.87e-05 | 2 | 151 | 2 | 24461634 | ||
| Pubmed | The block of ryanodine receptors selectively inhibits fetal myoblast differentiation. | 1.87e-05 | 2 | 151 | 2 | 12640042 | |
| Pubmed | Ryanodine receptor oligomeric interaction: identification of a putative binding region. | 1.87e-05 | 2 | 151 | 2 | 14722100 | |
| Pubmed | Translational dysregulation in cancer: eIF4A isoforms and sequence determinants of eIF4A dependence. | 1.87e-05 | 2 | 151 | 2 | 26614665 | |
| Pubmed | 1.87e-05 | 2 | 151 | 2 | 9015395 | ||
| Pubmed | Structural and functional interactions within ryanodine receptor. | 1.87e-05 | 2 | 151 | 2 | 26009179 | |
| Pubmed | 1.87e-05 | 2 | 151 | 2 | 32899693 | ||
| Pubmed | 1.87e-05 | 2 | 151 | 2 | 14592949 | ||
| Pubmed | 1.87e-05 | 2 | 151 | 2 | 8898078 | ||
| Pubmed | 1.87e-05 | 2 | 151 | 2 | 14550562 | ||
| Pubmed | 1.87e-05 | 2 | 151 | 2 | 29992445 | ||
| Pubmed | 1.87e-05 | 2 | 151 | 2 | 9799464 | ||
| Pubmed | Ryanodine receptors in human pancreatic beta cells: localization and effects on insulin secretion. | 1.87e-05 | 2 | 151 | 2 | 15033925 | |
| Pubmed | Dephosphorylation of cyclin-dependent kinases by type 2C protein phosphatases. | 1.87e-05 | 2 | 151 | 2 | 10580002 | |
| Pubmed | Expression and functional activity of ryanodine receptors (RyRs) during skeletal muscle development. | 1.87e-05 | 2 | 151 | 2 | 17118445 | |
| Pubmed | RyR3 amplifies RyR1-mediated Ca(2+)-induced Ca(2+) release in neonatal mammalian skeletal muscle. | 1.87e-05 | 2 | 151 | 2 | 11500519 | |
| Pubmed | 1.87e-05 | 2 | 151 | 2 | 16162496 | ||
| Pubmed | Altered ryanodine receptor expression in mild cognitive impairment and Alzheimer's disease. | 1.87e-05 | 2 | 151 | 2 | 21531043 | |
| Pubmed | 1.87e-05 | 2 | 151 | 2 | 16678258 | ||
| Pubmed | A cellular response linking eIF4AI activity to eIF4AII transcription. | 1.87e-05 | 2 | 151 | 2 | 22589333 | |
| Pubmed | 1.87e-05 | 2 | 151 | 2 | 12565913 | ||
| Pubmed | 1.87e-05 | 2 | 151 | 2 | 9192302 | ||
| Pubmed | 1.87e-05 | 2 | 151 | 2 | 7556644 | ||
| Pubmed | Regulation of eukaryotic initiation factor 4AII by MyoD during murine myogenic cell differentiation. | 1.87e-05 | 2 | 151 | 2 | 24466343 | |
| Pubmed | Ryanodine receptors in muscarinic receptor-mediated bronchoconstriction. | 1.87e-05 | 2 | 151 | 2 | 15894801 | |
| Pubmed | 1.87e-05 | 2 | 151 | 2 | 30542613 | ||
| Pubmed | 1.87e-05 | 2 | 151 | 2 | 15280431 | ||
| Pubmed | 1.87e-05 | 2 | 151 | 2 | 3046931 | ||
| Interaction | CDC42 interactions | IQGAP2 ARHGAP10 CDC42SE1 SUN1 WRN FKBP9 PSD3 CASP7 URB2 HUWE1 SLC1A3 RPL23 PTPN2 SBNO1 LNPEP AFG3L2 UGDH MKI67 FMN2 KIF14 ROCK1 TYW1 UQCRC2 UTRN ARHGEF6 EPHA5 | 4.84e-06 | 1323 | 150 | 26 | int:CDC42 |
| Cytoband | 7p11.1 | 1.07e-05 | 2 | 151 | 2 | 7p11.1 | |
| Cytoband | 5q15 | 3.15e-04 | 40 | 151 | 3 | 5q15 | |
| Cytoband | 2q24 | 5.80e-04 | 11 | 151 | 2 | 2q24 | |
| GeneFamily | Ryanodine receptors|Protein phosphatase 1 regulatory subunits | 1.74e-07 | 3 | 102 | 3 | 287 | |
| GeneFamily | EF-hand domain containing | 2.42e-04 | 219 | 102 | 7 | 863 | |
| GeneFamily | Cullins | 8.63e-04 | 8 | 102 | 2 | 1032 | |
| GeneFamily | ATP binding cassette subfamily B | 1.68e-03 | 11 | 102 | 2 | 806 | |
| GeneFamily | CD molecules|Type II classical cadherins | 2.36e-03 | 13 | 102 | 2 | 1186 | |
| GeneFamily | Rho GTPase activating proteins|BCH domain containing | 2.82e-03 | 50 | 102 | 3 | 721 | |
| GeneFamily | Protein phosphatases, Mg2+/Mn2+ dependent | 4.06e-03 | 17 | 102 | 2 | 701 | |
| GeneFamily | Protein tyrosine phosphatases, non-receptor type | 4.55e-03 | 18 | 102 | 2 | 812 | |
| GeneFamily | Aldehyde dehydrogenases | 5.06e-03 | 19 | 102 | 2 | 398 | |
| GeneFamily | Wnt family|Endogenous ligands | 5.06e-03 | 19 | 102 | 2 | 360 | |
| Coexpression | GSE3982_DC_VS_TH2_DN | 2.44e-06 | 199 | 151 | 9 | M5486 | |
| Coexpression | THUM_SYSTOLIC_HEART_FAILURE_DN | 7.12e-06 | 227 | 151 | 9 | M18441 | |
| Coexpression | GSE45881_CXCR6HI_VS_CXCR1LO_COLONIC_LAMINA_PROPRIA_UP | 2.18e-05 | 200 | 151 | 8 | M9889 | |
| Coexpression | GSE17721_PAM3CSK4_VS_GADIQUIMOD_24H_BMDC_UP | 2.18e-05 | 200 | 151 | 8 | M3979 | |
| Coexpression | GEORGES_CELL_CYCLE_MIR192_TARGETS | 2.95e-05 | 62 | 151 | 5 | M11038 | |
| Coexpression | LAKE_ADULT_KIDNEY_C2_PODOCYTES | 3.31e-05 | 212 | 151 | 8 | M39221 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | HNRNPDL DMXL2 SASH1 SWAP70 SMCHD1 WRN USP24 PSD3 THOC2 PPM1B ORC2 PTPN2 SLC25A12 AKAP9 KIF14 ROCK1 | 3.67e-05 | 856 | 151 | 16 | M4500 |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C7_PROLIFERATING_SCHWANN_CELL | ARHGAP42 GINS3 CCDC9B IQGAP2 FAHD2A CASP7 CAMK1 CDC14A HEPH JAK2 ARHGAP4 MKI67 KIF14 C1R POLQ PC UTRN ARHGEF6 | 3.82e-05 | 1054 | 151 | 18 | M45798 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#1 | RAB12 TTC39B IQGAP2 PCLO ZNF629 PSD3 SLC1A3 SLC25A12 CLCN6 ST18 ARHGEF6 | 1.03e-05 | 306 | 148 | 11 | Facebase_RNAseq_e10.5_Maxillary Arch_2500_K1 |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.33e-08 | 195 | 151 | 9 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.33e-08 | 195 | 151 | 9 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | LPS-antiTNF-Unknown-Endothelial-Pericyte_2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.46e-07 | 132 | 151 | 7 | 02491930097b75aaeedab9e8200711b0dc610944 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Upper_Layer|World / Primary Cells by Cluster | 4.27e-07 | 200 | 151 | 8 | db10f76938af553d1a2275bb02ef75dff3c3135b | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Upper_Layer-21|World / Primary Cells by Cluster | 4.27e-07 | 200 | 151 | 8 | 30a3e4aee12ec1b5acdce90f86c9733c27a7f6fc | |
| ToppCell | facs-Trachea-24m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l6-17|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.48e-06 | 177 | 151 | 7 | 8abdf1d970b2f15e17e185f3e612dd5065c88757 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.21e-06 | 184 | 151 | 7 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.21e-06 | 184 | 151 | 7 | 689a8af81a79a4bb3123cfa01958c953eab5de98 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.21e-06 | 184 | 151 | 7 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.21e-06 | 184 | 151 | 7 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | CV-Moderate-7|Moderate / Virus stimulation, Condition and Cluster | 3.32e-06 | 185 | 151 | 7 | a6c9203ce6c2892a4a369c9bcfb85720f01cbb3f | |
| ToppCell | CV-Moderate-7|CV / Virus stimulation, Condition and Cluster | 3.44e-06 | 186 | 151 | 7 | 8571956890fc9894d766ba294a28e376b4aba428 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_2_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.96e-06 | 190 | 151 | 7 | 0fea33f2dc1efa23aaa2da1c318482a52a313ff1 | |
| ToppCell | severe-low-quality_cells|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 4.39e-06 | 193 | 151 | 7 | 9337bc93e3904c7fc7c93c328518bcd6453b1e8c | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-3.5_mon-Proliferating-Cycling_Progenitors|3.5_mon / Sample Type, Dataset, Time_group, and Cell type. | 4.86e-06 | 196 | 151 | 7 | 5905f0e3061a6b98b7a33d64c782c3dda2cd51ef | |
| ToppCell | severe-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 5.02e-06 | 197 | 151 | 7 | 57ebd552f10d6278623b52a3d484d4b91ae1d028 | |
| ToppCell | TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Oligoastrocytoma|TCGA-Brain / Sample_Type by Project: Shred V9 | 1.86e-05 | 161 | 151 | 6 | 347edb0de10850b7d16c40945751033289289c9b | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Cycling_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.28e-05 | 167 | 151 | 6 | bc132b51dec4e8f1cd2b2cd89f83641976e09292 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.36e-05 | 168 | 151 | 6 | fc80e4fecfc92458eb627013a983041d8ca025a9 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.36e-05 | 168 | 151 | 6 | 315ca578c945aeeb77acda2727f3e6db8b43f43e | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m-Epithelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.36e-05 | 168 | 151 | 6 | b98af4043dfa5dfa4413e482879fad88de484675 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.36e-05 | 168 | 151 | 6 | e96859dbf51cf8c4def8ee8db132f4d874fb4381 | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m-Epithelial-hepatocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.36e-05 | 168 | 151 | 6 | 073b53d4cee6bc8c5c6fce51cf6cd9c316478f69 | |
| ToppCell | droplet-Liver-HEPATOCYTES|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.44e-05 | 169 | 151 | 6 | f195467438c589f87224bde7da720dea072d110c | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.44e-05 | 169 | 151 | 6 | 7785cab967a33560830c394c918d6ce625103858 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.69e-05 | 172 | 151 | 6 | 381ae1c3c07d0a424f43455ec571653b192a946a | |
| ToppCell | COVID-19-kidney-PCT-S3-2|kidney / Disease (COVID-19 only), tissue and cell type | 2.87e-05 | 174 | 151 | 6 | 5aa2fb631505600f37d2b87b02def7be139dc262 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.87e-05 | 174 | 151 | 6 | dbdcdec08f1fc69fcdb5d8a6d78df8ef9c374d89 | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m-Epithelial-Hepatocyte_(Periportal)|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.97e-05 | 175 | 151 | 6 | 5c38d4b6c03473d841e6203a7efaa6dcb2d59386 | |
| ToppCell | COVID-19-kidney-Podocyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.97e-05 | 175 | 151 | 6 | a73e3a65fd5c1e09cb0c2dae20c1a7bfcae49223 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Neuronal-neurons_A|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.06e-05 | 176 | 151 | 6 | 116741fef5895ca85057d2d31eca9eba5764ab44 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Neuronal-neurons_A-Branch_A1_(iMN)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.06e-05 | 176 | 151 | 6 | 5b707f58d164ee7a6a527dd5d053472ce9a631c1 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.16e-05 | 177 | 151 | 6 | 4d2cdb57b427a42085c5f9affa0967b15e84dec3 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.26e-05 | 178 | 151 | 6 | edc7143dc9959d36057cb9471681a23afcbc8cce | |
| ToppCell | 10x5'-lymph-node_spleen-Myeloid_Mac-Cycling_Myeloid-Mac|lymph-node_spleen / Manually curated celltypes from each tissue | 3.48e-05 | 180 | 151 | 6 | 4eea8366cdb82c356325ce88f09ad8b302c17a07 | |
| ToppCell | Epithelial-lung_neuroendocrine_cell_(PNEC)|World / Lineage, Cell type, age group and donor | 3.70e-05 | 182 | 151 | 6 | 57bf4ffb304324e2e392e196336a530d9f78fe0d | |
| ToppCell | droplet-Spleen-nan-18m|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.70e-05 | 182 | 151 | 6 | eeb5dfa4539e9ca5220f26bc2b65717ddcf13b6c | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.81e-05 | 183 | 151 | 6 | 3c516fe5083f02bad1f464ed284010b4131a833c | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.81e-05 | 183 | 151 | 6 | 9c2689d76fc6d30f5ab093428aa669d0a98953cf | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.93e-05 | 184 | 151 | 6 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Renal_corpuscle_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.93e-05 | 184 | 151 | 6 | 7294b379ce4cb8fa75e432559082f93cd106aaf5 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_VIP_PRSS8|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.05e-05 | 185 | 151 | 6 | 4c42bd3cd72f91f4d4ebb849069a03761a2cd662 | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 4.17e-05 | 186 | 151 | 6 | 23b8d51d20b05795a73892d3e20e0f9b6a207820 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-lung_neuroendocrine_cell_(PNEC)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.17e-05 | 186 | 151 | 6 | b45cce768e4bf91da194fd9660cab7520dfb15ac | |
| ToppCell | Adult-Epithelial-club_cell-D231|Adult / Lineage, Cell type, age group and donor | 4.30e-05 | 187 | 151 | 6 | ee59d7d3de5879738ff0b9c3ea5e4847fb48cb86 | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.30e-05 | 187 | 151 | 6 | 24c2a3962da364e46e98abeab5f8234376fa26bb | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 4.43e-05 | 188 | 151 | 6 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Degenerative_Podocyte|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.43e-05 | 188 | 151 | 6 | 9db778c1d9e622a68337212296e3a1ed8f771fa5 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-lung_neuroendocrine_cell_(PNEC)-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 4.43e-05 | 188 | 151 | 6 | c4c3b21ab723b0e9beff9ec84f8d68485f771528 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.70e-05 | 190 | 151 | 6 | 45df8fee00f8949937863159d7aa042e72748d9b | |
| ToppCell | CD8+_Memory_T_cell-CV-7|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | 4.84e-05 | 191 | 151 | 6 | 9454f642c3621370fa23640b631301346b300950 | |
| ToppCell | COVID-19_Severe-Plasmablast|World / disease group, cell group and cell class | 4.98e-05 | 192 | 151 | 6 | a333053fe2bd206c32790916bfc5fce904ab7f57 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Neuronal-neurons_B|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.98e-05 | 192 | 151 | 6 | 2f1c4ef693515ccc7231bd8c6641fad51d445d20 | |
| ToppCell | LPS_only-Stromal_mesenchymal|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.98e-05 | 192 | 151 | 6 | 162d8b5858d150ecbbd1c9bf2b19c6c9cd50a158 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.98e-05 | 192 | 151 | 6 | 4e47a02007f562f29ba5910df64d32a0167d0bd1 | |
| ToppCell | PBMC-Severe-Lymphocyte-B-Plasmablast|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 5.12e-05 | 193 | 151 | 6 | 227d82059a9f99937e0188ff57f2d0e485ebfe69 | |
| ToppCell | PBMC-Severe-Lymphocyte-B-Plasmablast-Plasmablast-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 5.12e-05 | 193 | 151 | 6 | 38bb14df7f05c29565a1c7f175fafe636e543bf8 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_B|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.12e-05 | 193 | 151 | 6 | ac227ddabfb3f021b1b39dba73f898517cd5a58e | |
| ToppCell | PBMC-Severe-Lymphocyte-B-Plasmablast-Plasmablast|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 5.12e-05 | 193 | 151 | 6 | 3ba6d44248690b80f4caf791d463e60f1ab816c4 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d14-21-Lymphocytic-Lymphocytic_B|Severe-critical_convalescent_d14-21 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.12e-05 | 193 | 151 | 6 | 89831e1007944e47719e58f23bfef5f1944cae23 | |
| ToppCell | COVID-19_Severe-Plasmablast|COVID-19_Severe / disease group, cell group and cell class | 5.12e-05 | 193 | 151 | 6 | 8074bcede261b85f9ae03ee372bd6d4b40384537 | |
| ToppCell | PBMC-Severe-Lymphocyte-B-Plasmablast|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.12e-05 | 193 | 151 | 6 | ce3873ece35fd2155ea235cb3c8bcd235cc0ebde | |
| ToppCell | PBMC-Severe-Lymphocyte-B-Plasmablast-Plasmablast|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.12e-05 | 193 | 151 | 6 | 8f57b0473a2c2c07f83e5fe70f16862b1bb3b514 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_B-B_cell|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.12e-05 | 193 | 151 | 6 | f4135615ee0118eec9e221becdd67888e0c2a112 | |
| ToppCell | PBMC-Mild-Myeloid-cDC-cDC-cDC_12|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.14e-05 | 118 | 151 | 5 | f0f40a0165156e3fc1584480b473b0e84e10d2cc | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 5.27e-05 | 194 | 151 | 6 | 6e13549f697f7478b34fe71f7dd9d63c5d3db22e | |
| ToppCell | PBMC-Mild-Myeloid-cDC-cDC-cDC_12|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 5.35e-05 | 119 | 151 | 5 | a6b359e7aafcc197f53eb5e19c3a905bc09497bb | |
| ToppCell | severe-B_cell|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 5.43e-05 | 195 | 151 | 6 | 0fc3c605609c9e6bdea15d73c45def2188ae5fb1 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.58e-05 | 196 | 151 | 6 | 85507488f83d8f71b3ee2ad5e5aa0b6ad6193873 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Layer_VI_Pan-area|World / Primary Cells by Cluster | 5.74e-05 | 197 | 151 | 6 | 79b9e7f2e8e33b3c547f716be5667156c48b0dfc | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Layer_VI_Pan-area-33|World / Primary Cells by Cluster | 5.74e-05 | 197 | 151 | 6 | d20f29088e9afd8a960d6f680075c380e550f8a7 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.74e-05 | 197 | 151 | 6 | 107cb153ea7fc74bbd244dbb9d0499c0a8506724 | |
| ToppCell | LPS_only-Endothelial-Endothelial-FOXM1|LPS_only / Treatment groups by lineage, cell group, cell type | 5.74e-05 | 197 | 151 | 6 | 038fd92750257d43d5e980fd06d77742b543f11a | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_secretory|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.91e-05 | 198 | 151 | 6 | af399569c718f5fd971d73a7926768c9311002a3 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.91e-05 | 198 | 151 | 6 | 8ab40fae14fe02e39bc8c8da187a5cd60c787643 | |
| ToppCell | COVID-19-COVID-19_Severe-Lymphocyte-B-Plasmablast|COVID-19_Severe / Disease, condition lineage and cell class | 6.07e-05 | 199 | 151 | 6 | e6422b65e22e5aa8dfaebdae5be76dd78b978604 | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 6.07e-05 | 199 | 151 | 6 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | Fibroblasts|World / lung cells shred on cell class, cell subclass, sample id | 6.07e-05 | 199 | 151 | 6 | e2b6752fcabd5249a166486ae6796f2c97c1fcaf | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Parietal_and_Temporal-6|World / Primary Cells by Cluster | 6.07e-05 | 199 | 151 | 6 | 1b1bccf4293f11048709d15a3c892c0edf3da3d2 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.07e-05 | 199 | 151 | 6 | 19a97e27a4758e794ce7246d295e112b47931a48 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Parietal_and_Temporal|World / Primary Cells by Cluster | 6.07e-05 | 199 | 151 | 6 | 4bee94c116c0da5eba951cb4cea7cc9dcdd6e30f | |
| ToppCell | Neuronal-Inhibitory-iA-iA_1(SST_PAX6)-PAX6-TSPAN12-L1-2|Neuronal / cells hierarchy compared to all cells using T-Statistic | 6.24e-05 | 200 | 151 | 6 | 523d799eb315b33b77e02d5b7db63dad8450c4e1 | |
| ToppCell | control|World / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 6.24e-05 | 200 | 151 | 6 | 97f36d2c197e03d93a1fc59949d77ae90f6e6a9a | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Astrocyte-Astrocyte-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.24e-05 | 200 | 151 | 6 | 7a8160e6477708f22e48c609bf8f43f3715dcb03 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_1(SST_PAX6)-PAX6-TSPAN12|Neuronal / cells hierarchy compared to all cells using T-Statistic | 6.24e-05 | 200 | 151 | 6 | e5cef95e563a6e793ade190ce88c999bfa0af460 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Astrocyte-Astrocyte|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.24e-05 | 200 | 151 | 6 | d0812817ef99608994193787a62d39adeb2070ca | |
| ToppCell | Neuronal-Inhibitory-iA-iA_1(SST_PAX6)-NMBR|Neuronal / cells hierarchy compared to all cells using T-Statistic | 6.24e-05 | 200 | 151 | 6 | 862db57d043bdf3cb059fbfc8b29bc1eafdf64ec | |
| ToppCell | Neuronal-Inhibitory-iA-iA_1(SST_PAX6)-NMBR--L1|Neuronal / cells hierarchy compared to all cells using T-Statistic | 6.24e-05 | 200 | 151 | 6 | a91345f268f13170c27309333603eb82400c9947 | |
| ToppCell | Neuronal-Excitatory-eB(RORB)-SEMA3E-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 6.24e-05 | 200 | 151 | 6 | 1a3d29a580d1b405a74869a1da3e818c581fc559 | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Pericyte|Control_saline / Treatment groups by lineage, cell group, cell type | 6.24e-05 | 200 | 151 | 6 | cb7ef774b6d300f8019c5b16a04e3ebd165e4f1c | |
| ToppCell | mild-B_naive|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 6.24e-05 | 200 | 151 | 6 | 222789b897e2a683bbfd1d00b6fd8705015d90df | |
| ToppCell | Neuronal-Excitatory-eB(RORB)-SEMA3E---L4-6|Neuronal / cells hierarchy compared to all cells using T-Statistic | 6.24e-05 | 200 | 151 | 6 | 6f9ed8fe9cda91185c3a1a675353e11b8fec6ef1 | |
| ToppCell | Neuronal-Inhibitory-iA-iA_1(SST_PAX6)-NMBR-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 6.24e-05 | 200 | 151 | 6 | d416a7be1a4e6232fb58a9687774da24821f1fdd | |
| ToppCell | Control_saline-Mesenchymal_myocytic-Pericyte-Pericyte_3|Control_saline / Treatment groups by lineage, cell group, cell type | 6.24e-05 | 200 | 151 | 6 | b0866b497aa71d06cef25f9a335fa584e95fa7e0 | |
| ToppCell | Neuronal-Excitatory-eB(RORB)-SEMA3E--|Neuronal / cells hierarchy compared to all cells using T-Statistic | 6.24e-05 | 200 | 151 | 6 | 86705dfc05b3e1576543b93883c88fb55b742855 | |
| ToppCell | Neuronal-Excitatory-eB(RORB)-SEMA3E|Neuronal / cells hierarchy compared to all cells using T-Statistic | 6.24e-05 | 200 | 151 | 6 | db194b4f524fd008b3c5b4b6014b436190a1b87a | |
| ToppCell | NS-control|NS / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 6.24e-05 | 200 | 151 | 6 | ecbe89ff95d046155b984c8c150e0b9e7278f839 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-Astrocyte|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.24e-05 | 200 | 151 | 6 | cd54ddf1919c98e84b7e4aba85b374fc8b407206 | |
| ToppCell | E16.5-samps-Mesenchymal-Myofibroblast-myofibroblast_-_immature|E16.5-samps / Age Group, Lineage, Cell class and subclass | 7.85e-05 | 129 | 151 | 5 | 5e4783cc63afdeaebdfaecb72f95f3efc8d3c4a3 | |
| ToppCell | PBMC-Control-Lymphocyte-B-B_cell-B_naive-B_naive-4|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.39e-05 | 134 | 151 | 5 | 8707210b2a5d33baa1d204e9e2ed8921181cb309 | |
| Drug | cis-diammineplatinum(II | 2.69e-07 | 3 | 148 | 3 | CID000159790 | |
| Drug | 2-hydroxyheptanoic acid | 2.69e-07 | 3 | 148 | 3 | CID002750949 | |
| Drug | 8N3-cADPR | 2.69e-07 | 3 | 148 | 3 | CID000127713 | |
| Drug | aminodantrolene | 2.69e-07 | 3 | 148 | 3 | CID009570289 | |
| Drug | 2-hydroxycarbazole | 2.69e-07 | 3 | 148 | 3 | CID000093551 | |
| Drug | Ryanodyl 3-(pyridine-3-carboxylate | 2.69e-07 | 3 | 148 | 3 | CID005748312 | |
| Drug | PCB 66 | 5.46e-07 | 11 | 148 | 4 | CID000036185 | |
| Drug | PCB74 | 1.07e-06 | 4 | 148 | 3 | CID000036218 | |
| Drug | 148504-47-6 | 1.07e-06 | 4 | 148 | 3 | CID006444275 | |
| Drug | SC 38249 | 1.07e-06 | 4 | 148 | 3 | CID000134834 | |
| Drug | AC1L1U7A | 1.07e-06 | 4 | 148 | 3 | CID000035682 | |
| Drug | methylcoumarin | 4.89e-06 | 18 | 148 | 4 | CID000007092 | |
| Drug | chloro-m-cresol | 5.31e-06 | 6 | 148 | 3 | CID000012008 | |
| Drug | MBED | 5.31e-06 | 6 | 148 | 3 | CID000129958 | |
| Drug | AC1O528X | 5.31e-06 | 6 | 148 | 3 | CID006475857 | |
| Drug | NSC114784 | 5.31e-06 | 6 | 148 | 3 | CID000419425 | |
| Drug | Trifluridine [70-00-8]; Down 200; 13.6uM; MCF7; HT_HG-U133A | 5.42e-06 | 195 | 148 | 9 | 3559_DN | |
| Drug | Chlorthalidone [77-36-1]; Up 200; 11.8uM; MCF7; HT_HG-U133A | 6.14e-06 | 198 | 148 | 9 | 6800_UP | |
| Drug | Chlorpheniramine maleate [113-92-8]; Down 200; 10.2uM; MCF7; HT_HG-U133A | 6.14e-06 | 198 | 148 | 9 | 2217_DN | |
| Drug | Phenindione [83-12-5]; Down 200; 18uM; HL60; HG-U133A | 6.39e-06 | 199 | 148 | 9 | 1718_DN | |
| Drug | 2,2',3,5',6-pentachlorobiphenyl | 7.66e-06 | 20 | 148 | 4 | ctd:C032904 | |
| Drug | [[(2R,3S,4R)-5-(2-amino-6-oxo-3H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2R,3S,4R,5R)-3,4,5-trihydroxyoxolan-2-yl]methyl hydrogen phosphate | 9.24e-06 | 7 | 148 | 3 | CID009547999 | |
| Drug | Azumoleno | 9.24e-06 | 7 | 148 | 3 | CID000056259 | |
| Drug | Br2BAPTA | 9.24e-06 | 7 | 148 | 3 | CID003081001 | |
| Drug | ts M | 1.48e-05 | 48 | 148 | 5 | CID000428025 | |
| Drug | T0702 | 1.95e-05 | 25 | 148 | 4 | CID000005908 | |
| Drug | PCB 95 | 3.12e-05 | 10 | 148 | 3 | CID000038012 | |
| Drug | creatine | 3.95e-05 | 193 | 148 | 8 | CID000000586 | |
| Drug | LOPAC | 4.12e-05 | 30 | 148 | 4 | CID000062696 | |
| Drug | cyclic d(ApAp | 4.20e-05 | 2 | 148 | 2 | CID000188955 | |
| Drug | 5'-adenylyl (beta,gamma-methylene)diphosphonate | 4.20e-05 | 2 | 148 | 2 | ctd:C005147 | |
| Drug | R 478 | 4.27e-05 | 11 | 148 | 3 | CID000084223 | |
| Drug | 8-amino-cADPR | 4.27e-05 | 11 | 148 | 3 | CID003081323 | |
| Drug | (R) -Naproxen sodium salt [26159-34-2]; Down 200; 15.8uM; PC3; HT_HG-U133A | 4.57e-05 | 197 | 148 | 8 | 7146_DN | |
| Drug | M-HN | 4.71e-05 | 31 | 148 | 4 | CID000015450 | |
| Drug | Vigabatrin [60643-86-9]; Down 200; 31uM; PC3; HT_HG-U133A | 4.73e-05 | 198 | 148 | 8 | 6314_DN | |
| Drug | 6-methylpurine-2'-deoxyriboside | 4.81e-05 | 61 | 148 | 5 | CID000097184 | |
| Drug | 17beta-estradiol glucuronide | 5.35e-05 | 32 | 148 | 4 | CID000066424 | |
| Drug | Ryanodine | 5.67e-05 | 12 | 148 | 3 | ctd:D012433 | |
| Drug | tBuBHQ | 8.72e-05 | 69 | 148 | 5 | CID000002374 | |
| Drug | Digocin | 9.34e-05 | 70 | 148 | 5 | CID000003062 | |
| Drug | mag-fura-2 | 9.58e-05 | 37 | 148 | 4 | CID000123839 | |
| Drug | 1,2-dichlorohexafluorocyclobutane | 9.58e-05 | 37 | 148 | 4 | CID000009643 | |
| Drug | sulfate | SUMF2 VPS4A WRN FAHD2A CASP7 SRP54 ITIH4 B3GAT3 JAK2 ARHGAP4 SLC22A6 THBS4 EIF4A2 AFG3L2 UGDH ABCB11 ROCK1 ALDH5A1 MARCO CCS EPHA5 | 9.62e-05 | 1292 | 148 | 21 | CID000001117 |
| Drug | FPL 64176 | 1.16e-04 | 15 | 148 | 3 | CID000003423 | |
| Drug | Gvapspat amide | 1.16e-04 | 15 | 148 | 3 | CID000125015 | |
| Drug | 1,1'-diheptyl-4,4'-bipyridinium | 1.25e-04 | 3 | 148 | 2 | CID000080262 | |
| Drug | flubendiamide | 1.25e-04 | 3 | 148 | 2 | CID011193251 | |
| Drug | phenobarbital | CYP2F1 ABCB5 ABCC6 B3GAT3 PTPN2 UGDH ABCB11 PCBP2 ALDH5A1 ALDH7A1 | 1.27e-04 | 360 | 148 | 10 | CID000004763 |
| Disease | congenital myopathy 1A (implicated_via_orthology) | 1.21e-07 | 3 | 147 | 3 | DOID:3529 (implicated_via_orthology) | |
| Disease | malignant hyperthermia (implicated_via_orthology) | 1.21e-07 | 3 | 147 | 3 | DOID:8545 (implicated_via_orthology) | |
| Disease | Conventional (Clear Cell) Renal Cell Carcinoma | 1.02e-04 | 148 | 147 | 6 | C0279702 | |
| Disease | fibrinogen measurement, coronary artery disease | 1.26e-04 | 154 | 147 | 6 | EFO_0001645, EFO_0004623 | |
| Disease | X-linked mental retardation with cerebellar hypoplasia and distinctive facial appearance (implicated_via_orthology) | 1.47e-04 | 4 | 147 | 2 | DOID:0080311 (implicated_via_orthology) | |
| Disease | total lipids in medium VLDL | 1.54e-04 | 54 | 147 | 4 | EFO_0022153 | |
| Disease | coronary artery disease | ARHGAP42 TTC39B TDRD15 MIA3 SWAP70 PSD3 ITIH4 PPM1A LNPEP KIAA1217 MORF4L1 FMN2 C1R ALDH5A1 ABCG8 PARP12 | 3.15e-04 | 1194 | 147 | 16 | EFO_0001645 |
| Disease | Sarcomatoid Renal Cell Carcinoma | 4.64e-04 | 128 | 147 | 5 | C1266043 | |
| Disease | Chromophobe Renal Cell Carcinoma | 4.64e-04 | 128 | 147 | 5 | C1266042 | |
| Disease | Collecting Duct Carcinoma of the Kidney | 4.64e-04 | 128 | 147 | 5 | C1266044 | |
| Disease | Papillary Renal Cell Carcinoma | 4.64e-04 | 128 | 147 | 5 | C1306837 | |
| Disease | Renal Cell Carcinoma | 4.64e-04 | 128 | 147 | 5 | C0007134 | |
| Disease | osteoporosis | 4.93e-04 | 73 | 147 | 4 | EFO_0003882 | |
| Disease | cholesteryl ester 24:4 measurement | 5.09e-04 | 7 | 147 | 2 | EFO_0021447 | |
| Disease | polyunsaturated fatty acid measurement | 5.15e-04 | 131 | 147 | 5 | EFO_0010733 | |
| Disease | Cholestasis of pregnancy | 6.77e-04 | 8 | 147 | 2 | C0268318 | |
| Disease | cystic fibrosis (implicated_via_orthology) | 8.67e-04 | 9 | 147 | 2 | DOID:1485 (implicated_via_orthology) | |
| Disease | lipoprotein measurement, phospholipid measurement | 8.75e-04 | 85 | 147 | 4 | EFO_0004639, EFO_0004732 | |
| Disease | very low density lipoprotein cholesterol measurement, cholesterol:total lipids ratio | 8.88e-04 | 222 | 147 | 6 | EFO_0008317, EFO_0020943 | |
| Disease | triglycerides:total lipids ratio, low density lipoprotein cholesterol measurement | 9.50e-04 | 150 | 147 | 5 | EFO_0004611, EFO_0020947 | |
| Disease | triglycerides:total lipids ratio, very low density lipoprotein cholesterol measurement | 9.52e-04 | 225 | 147 | 6 | EFO_0008317, EFO_0020947 | |
| Disease | triglyceride measurement, low density lipoprotein cholesterol measurement | 1.49e-03 | 166 | 147 | 5 | EFO_0004530, EFO_0004611 | |
| Disease | low density lipoprotein cholesterol measurement, alcohol consumption measurement | 1.54e-03 | 99 | 147 | 4 | EFO_0004611, EFO_0007878 | |
| Disease | response to angiotensin-converting enzyme inhibitor, Cough | 1.57e-03 | 46 | 147 | 3 | EFO_0005325, HP_0012735 | |
| Disease | Oligospermia | 1.57e-03 | 12 | 147 | 2 | C0028960 | |
| Disease | low density lipoprotein cholesterol measurement, alcohol drinking | 1.72e-03 | 102 | 147 | 4 | EFO_0004329, EFO_0004611 | |
| Disease | extracellular matrix protein 1 measurement | 1.85e-03 | 13 | 147 | 2 | EFO_0008126 | |
| Disease | Mental Retardation, X-Linked Nonsyndromic | 1.85e-03 | 13 | 147 | 2 | C3501611 | |
| Disease | cholesteryl ester measurement | 1.87e-03 | 257 | 147 | 6 | EFO_0010351 | |
| Disease | cholesteryl esters to total lipids in small VLDL percentage | 1.89e-03 | 49 | 147 | 3 | EFO_0022256 | |
| Disease | myocardial infarction | 1.92e-03 | 350 | 147 | 7 | EFO_0000612 | |
| Disease | coronary artery calcification | 1.94e-03 | 450 | 147 | 8 | EFO_0004723 | |
| Disease | very low density lipoprotein cholesterol measurement, cholesteryl esters:total lipids ratio | 2.14e-03 | 264 | 147 | 6 | EFO_0008317, EFO_0020944 | |
| Disease | heel bone mineral density, urate measurement | 2.23e-03 | 182 | 147 | 5 | EFO_0004531, EFO_0009270 | |
| Disease | insulin measurement | 2.27e-03 | 267 | 147 | 6 | EFO_0004467 | |
| Disease | coronary artery disease, factor VII measurement | 2.34e-03 | 111 | 147 | 4 | EFO_0001645, EFO_0004619 | |
| Disease | factor VIII measurement, coronary artery disease | 2.50e-03 | 113 | 147 | 4 | EFO_0001645, EFO_0004630 | |
| Disease | factor XI measurement, coronary artery disease | 2.66e-03 | 115 | 147 | 4 | EFO_0001645, EFO_0004694 | |
| Disease | Colorectal Carcinoma | CCDC9B ABCB5 FSTL5 WRN CDC14A ABCC6 AKAP9 MKI67 ABCB11 UQCRC2 | 2.80e-03 | 702 | 147 | 10 | C0009402 |
| Disease | von Willebrand factor measurement, coronary artery disease | 2.92e-03 | 118 | 147 | 4 | EFO_0001645, EFO_0004629 | |
| Disease | spine bone mineral density | 3.01e-03 | 119 | 147 | 4 | EFO_0007701 | |
| Disease | omega-6 polyunsaturated fatty acid measurement | 3.13e-03 | 197 | 147 | 5 | EFO_0005680 | |
| Disease | response to phenylephrine | 3.19e-03 | 17 | 147 | 2 | EFO_0010152 | |
| Disease | very low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio | 3.46e-03 | 291 | 147 | 6 | EFO_0008317, EFO_0020946 | |
| Disease | coronary artery disease, plasminogen activator inhibitor 1 measurement | 3.87e-03 | 63 | 147 | 3 | EFO_0001645, EFO_0004792 | |
| Disease | urate measurement, bone density | 3.96e-03 | 619 | 147 | 9 | EFO_0003923, EFO_0004531 | |
| Disease | Cholecystitis | 3.99e-03 | 19 | 147 | 2 | HP_0001082 | |
| Disease | response to vaccine, cytokine measurement | 4.25e-03 | 131 | 147 | 4 | EFO_0004645, EFO_0004873 | |
| Disease | low density lipoprotein cholesterol measurement, physical activity | 4.41e-03 | 66 | 147 | 3 | EFO_0003940, EFO_0004611 | |
| Disease | exercise test | 4.42e-03 | 20 | 147 | 2 | EFO_0004328 | |
| Disease | free cholesterol measurement, very low density lipoprotein cholesterol measurement | 4.54e-03 | 215 | 147 | 5 | EFO_0008317, EFO_0008591 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| TGKGVEQELQGNSIM | 626 | Q5DID0 | |
| QQQGDVKTGAMKNLL | 261 | Q14146 | |
| MKQEEQLQRQGRGSD | 316 | O94766 | |
| LEGQRLQGIMQEFQK | 3431 | Q99996 | |
| IQMKQQQRNRLGSGG | 361 | Q9Y6R9 | |
| GEDIKNLGNVIFMSQ | 441 | Q15052 | |
| LMSNGIITFKNEVGQ | 576 | Q93034 | |
| TGAVQEQMRSKGNRD | 56 | Q9NRR8 | |
| IGMVENFNQALKEIG | 106 | P78537 | |
| TQVGKQVGLMVQERF | 276 | P49419 | |
| IVQFGMNEKVGQISF | 661 | Q9Y4W6 | |
| GNLSKTQNMERFGED | 366 | Q9UNH5 | |
| KGAQMSGGQKQRIAI | 521 | Q2M3G0 | |
| KKNDGQFTVIQLVGM | 766 | P54756 | |
| GGQMSGGQKQRVAIA | 556 | O95342 | |
| LGIQNLSFKVRSGQM | 86 | Q9H221 | |
| KQSIFRNIGAGVMQI | 2986 | Q8TDJ6 | |
| VDGKNVDMAGFIANN | 1626 | Q9NYQ6 | |
| NNMGQKRQTEESIGI | 2066 | Q96M86 | |
| RQRIIGGQKAKMGNF | 461 | P00736 | |
| MEDVFQNLTQDGKGI | 656 | A8MX76 | |
| FLNGKSVGVEMNTQN | 1316 | Q96SN8 | |
| GLVKATGRNMEQFQV | 116 | Q14624 | |
| TRQQGEKFAQQITGM | 166 | Q6IQ22 | |
| KQVAEQFLNMRGGLG | 231 | P22695 | |
| VEFGARMVNIDGKQI | 41 | Q8WUD1 | |
| QFSIQILRNFGMGKR | 126 | P24903 | |
| DDIVNSLQKMQNKGG | 56 | Q8TBF8 | |
| FLQQLGKGNFGSVEM | 851 | O60674 | |
| MGKQAEEQQKFGERV | 256 | Q9H3S7 | |
| NKIMTEKYNGNRIGL | 306 | P17706 | |
| SKNQQDDGKMFIGGL | 141 | O14979 | |
| QKANQEQYAEGKMRG | 116 | Q9UBU8 | |
| EGNAQLDKMGFTIIR | 386 | A1A4S6 | |
| VILAIGNFMNKGQRG | 801 | Q86T65 | |
| VLMSGVKNNVGRGIN | 91 | Q92520 | |
| NVLVTQRKGNFFMGG | 146 | Q15038 | |
| VKMTLNVGGETENNG | 141 | Q15058 | |
| MFNGIISIRNKNGEE | 151 | Q9HBG6 | |
| ERESQGQGEMFLQKA | 2146 | Q6PRD1 | |
| EGGLRAQMDQVKSQG | 591 | Q96EF0 | |
| RQMIGEFLGNRQKQF | 571 | Q6DN90 | |
| ESKNMVVNGRRNGGK | 6 | Q4FZB7 | |
| QDNGINQKRDGMVSK | 391 | Q5CZC0 | |
| EEQAQKQSGMEQGRL | 366 | Q6ZUT6 | |
| GGTNVRAEVQKLQME | 136 | P60842 | |
| NGFMQQKGREQKIRL | 1981 | Q9Y6V0 | |
| KNMFTNQDRNGDGKV | 111 | Q75LS8 | |
| GMDFIGRDALLQQKQ | 746 | Q8NCN5 | |
| TNGAVFVNGKEMTNQ | 356 | Q8IUI8 | |
| QQIQGSRIGGAQEME | 1226 | Q14999 | |
| FSGGEKQTMQNLNDR | 136 | Q2M2I5 | |
| ERGLLSGNEKVTMQN | 71 | Q7Z3Z0 | |
| QNMIRKAQEDGSQGF | 986 | O75581 | |
| FIVGEMKNLSQDVNG | 361 | Q9UIQ6 | |
| GEVVQSGNTNQMVFK | 241 | Q96GK7 | |
| VLMQNQKGKGEAGNS | 3181 | P46013 | |
| FAALEGMNGIQKFQI | 4311 | Q7Z6Z7 | |
| QMSGAQIKIANATEG | 321 | P57721 | |
| MEQKQLQKRFGGFTG | 121 | Q13519 | |
| GDTQQTQAMAKVALG | 851 | Q7Z442 | |
| NQESSRVKGFMIQDG | 46 | Q8N475 | |
| QGAKINEIRQMSGAQ | 306 | Q15366 | |
| GQMQKQNGGKAVDER | 546 | Q9H0J9 | |
| MRKLQLGTSQEGQGQ | 316 | Q14012 | |
| NAGVIVNNKGEMKGS | 101 | P62829 | |
| MFTNQDRNGDGKVTA | 541 | O95302 | |
| VTENRGNEKEFMKGN | 636 | P51797 | |
| NEVNKNEGMSGLFGL | 1666 | Q9H799 | |
| EQYQVVIQAKDMGGQ | 231 | Q9Y6N8 | |
| NRKGGTNGVQQLSKM | 936 | Q8TD26 | |
| GLRFEGALKNQMGQV | 686 | Q86TI2 | |
| VIGNMKEQGQALREF | 256 | P43003 | |
| ASMKEGKQGIQRNQE | 561 | O75417 | |
| GRSEVFLKMGKNNQS | 146 | Q9Y375 | |
| TQRQLMQERAEEGKG | 1701 | Q9BV73 | |
| RQAVLKGMGSGQLQN | 71 | O14618 | |
| IIINNKNFDKVTGMG | 71 | P55210 | |
| IGGTNVRNEMQKLQA | 136 | Q14240 | |
| NFTQNPGMFRIKGEQ | 136 | Q9UEW3 | |
| EQYQVLIQAKDMGGQ | 231 | P55289 | |
| LFGLGMNQDKGSRKQ | 1271 | Q9NZ56 | |
| NIVQGRRMVKANSQG | 476 | Q7Z3Z3 | |
| NQQLSEMAAGKGRGR | 526 | Q9H4Q3 | |
| MAFNDLLQQVGGVGR | 1 | Q4U2R8 | |
| NNIGKFLNRILGMEV | 1101 | A3KN83 | |
| AGREVEKVFNGLSNM | 61 | Q6UWP8 | |
| FERQNKAEGLGMVNE | 3846 | P21817 | |
| DGTVINRQNGEKVMA | 3861 | P21817 | |
| NAFERQNKAEGLGMV | 3806 | Q92736 | |
| GEMKVEQLFQEFGNR | 81 | O43781 | |
| KAIENIRQMGGNTNT | 501 | A6NMZ7 | |
| MQALKEGQGGEKNIQ | 111 | Q5VW36 | |
| RKMQLSGNGLEEQAA | 166 | Q6ZQY2 | |
| DSQMLRGEKSQQIIG | 396 | Q13416 | |
| GNRQKMVKALGNSEE | 2511 | P46939 | |
| KLGNGQATSMVQLQG | 21 | Q8NBJ7 | |
| GLKRGDQIMEVNGQN | 571 | Q8TEU7 | |
| AVIDNGRGMTSKQLN | 181 | A6NHR9 | |
| AEAMKKNLRVGNGFE | 361 | P51649 | |
| QNVIMFVGLQGSGKT | 101 | P61011 | |
| MERGLFQTGQKGLND | 171 | Q9BRX5 | |
| KNVIGLQMGTNRGAS | 171 | P37802 | |
| FVDFGNKQLVGENML | 1046 | B5MCY1 | |
| NGEVGGDRNEKMKNQ | 1436 | Q5JRA6 | |
| IGEQGMNLSGGQKQR | 746 | O95255 | |
| YRIGGVNSKVQKLMN | 416 | A6NI28 | |
| KGGEMEILNNTDNQG | 856 | Q13576 | |
| GKLGIANAQMDFQVE | 711 | Q06033 | |
| QGNTVQLQGMRKGAA | 661 | Q9BQS7 | |
| EQINDEMKRSGQLGI | 276 | P13521 | |
| SADRRQMQEQGKGNL | 16 | Q5T5P2 | |
| SGQMVGQKVGNEIDR | 86 | Q8NDV1 | |
| TIAFGMGINKADIRQ | 821 | Q14191 | |
| EKERIQNAGGSVMIQ | 176 | O75688 | |
| NFSGRIEGIQKAIMD | 16 | Q9BWV2 | |
| NQRLFGGDMEKFIQS | 501 | P98171 | |
| RKMTERGDELQQAGQ | 1406 | Q9NRC6 | |
| QTKVIDMGGRQIFNN | 341 | O60284 | |
| KTRMQNQRGSGSVVG | 351 | O75746 | |
| MVQGVGISFAKSNKQ | 361 | P35443 | |
| VATAIGMDQRIGNKF | 251 | O60701 | |
| GFLKNQIFSGIQMTR | 96 | Q8N587 | |
| RKYNGAIQVVMNQDG | 236 | P09544 | |
| MAQQRNGVIFQEGGE | 746 | Q8NI27 | |
| FVQDENMINFIKGGL | 251 | Q5VTQ0 | |
| ERENVFGKTLNLGMN | 111 | Q9HCZ1 | |
| DAGMIGNQVNRKVLN | 71 | Q5VZE5 | |
| GKRERKQSFMGNSGN | 16 | Q9ULX5 | |
| EKERIQNAGGSVMIQ | 171 | P35813 | |
| NAFERQNKAEGLGMV | 3696 | Q15413 | |
| SGQQKNIGMVEIRGN | 51 | A8MWD9 | |
| VQNMEGDKSQQLGRV | 421 | X6R8R1 | |
| NNLQIAVGRMQKGID | 1001 | Q99250 | |
| AKGSEEQGRVLMNLQ | 186 | Q9H1J7 | |
| RAGEQGEAMKQFDLN | 1521 | Q5JSZ5 | |
| NQKGIMRQTSKGEDV | 161 | O94885 | |
| RQVVESVGNQMGVGK | 91 | Q9BVS4 | |
| AKAGQEFARNNLMGD | 436 | Q6UW63 | |
| AQLTKQYRGNEGQMR | 826 | Q13464 | |
| KMGRDQIFKNTFQGI | 1791 | Q9UPU5 | |
| DQRLAEQKMAQTGRG | 1111 | Q9ULD9 | |
| LIGNGQFSKGMDRQT | 181 | Q9UH65 | |
| NNMGSQGIQETGKTR | 561 | Q96DT7 | |
| QKLQARVDQMEGGAA | 391 | O94901 | |
| KEQQEEKSGLFRNMG | 331 | Q9NV66 | |
| KIKGIVENMGINANN | 906 | Q9NYU1 | |
| KGFNDEGIFMQHQRI | 576 | Q9UEG4 | |
| QAEISQIMNNGRKGA | 226 | Q9NYI0 | |
| SKIVGDLAQFMVQNG | 911 | P11498 | |
| EQQEEKSGLFRNMGR | 286 | Q6NUM6 | |
| RIKTEFLVQMQGVGN | 246 | Q9UN37 |